NCT01214720View on ClinicalTrials.gov

A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

607

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Pancreatic Cancer
Interventions
DRUG

bevacizumab [Avastin]

Intervenous repeating dose

Trial Locations (101)

11

Lima

18

Lima

333

Kueishan

1009

Auckland

1070

Brussels

1090

Vienna

1200

Brussels

2020

Antwerp

2031

Sydney

2050

Camperdown

2065

St Leonards

2217

Sydney

2610

Wilrijk

3000

Leuven

3002

Melbourne

3011

Footscray

3084

Heidelberg

3128

Melbourne

5011

Adelaide

5020

Salzburg

5037

Kurralta Park

6020

Innsbruck

7506

Cape Town

8036

Graz

10043

Orbassano

11883

Stockholm

13273

Marseille

13353

Berlin

14004

Córdoba

16132

Genova

20249

Hamburg

24128

Bergamo

25030

Besançon

25124

Brescia

28040

Madrid

33000

Bordeaux

39008

Santander

39130

Magdeburg

40138

Bologna

41061

Mönchengladbach

43100

Parma

44281

Kfar Saba

44805

Saint-Herblain

44892

Bochum

46009

Valencia

46010

Valencia

49100

Petah Tikva

53127

Bonn

54290

Trier

55101

Mainz

66100

Chieti

67091

Strasbourg

69120

Heidelberg

71013

San Giovanni Rotondo

75674

Paris

75679

Paris

76031

Rouen

76100

Rehovot

80131

Napoli

81377

München

87042

Limoges

92104

Boulogne-Billancourt

92118

Clichy

100036

Beijing

100071

Beijing

119228

Singapore

169610

Singapore

200433

Shanghai

6423906

Tel Aviv

T6G 1Z2

Edmonton

V5Z 4E6

Vancouver

K1H 8L6

Ottawa

M5G 2M9

Toronto

H2W 1S6

Montreal

G1R 2J6

Québec

656 53

Brno

500 05

Hradec Králové

00029

Helsinki

06120

Halle

04103

Leipzig

1105 AZ

Amsterdam

Unknown

Christchurch

44-101

Gliwice

20-081

Lublin

71-730

Szczecin

53-413

Wroclaw

0001

Pretoria

03010

Alicante

08035

Barcelona

08036

Barcelona

08041

Barcelona

08907

Barcelona

03203

Elche

00112

Taipei

G11 6NT

Glasgow

LE1 5WW

Leicester

SW3 6JJ

London

M20 4BX

Manchester

HA6 2RN

Northwood

SM2 5PT

Sutton

TR1 3LJ

Truro

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01214720 - A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter